Product Information
AMBRISENTAN 10 MG TABLET is a generic product labeled by Apotex Corp., priced at $8.2094 per EA under NDC 60505455303. Its NADAC has been published 40 times since Nov 19, 2025.
FDA first approved this application on May 19, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Apotex Corp.NDC
60505455303
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMBRISENTANApproval Type
Generic (ANDA)
FDA Application
ANDA210701FDA Approved
5/19/2022
TE Code
AB
On Market Since
9/19/2022
Pharmacological Classes
Price Statistics
The NADAC for AMBRISENTAN 10 MG TABLET has been published 40 times since Nov 19, 2025, and over the history we have for it it has declined 16.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.2094 per EA |
|---|---|
| All-time high | $9.8462 (Dec 10, 2025) |
| All-time low | $8.2094 (Aug 19, 2026) |
| 52-week high | $9.8462 |
| 52-week low | $8.2094 |
| Median price | $8.5213 |
| Average price | $8.6933 |
| Largest weekly change | -7.8% (Dec 17, 2025) |
| Weeks tracked | 40 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMBRISENTAN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMBRISENTAN 10 MG TABLET, manufactured by Apotex Corp., is $8.2094 per EA (NDC 60505455303), effective Aug 19, 2026.
How has the price of AMBRISENTAN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for AMBRISENTAN 10 MG TABLET has declined 16.6%. It has been tracked across 40 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for AMBRISENTAN 10 MG TABLET?
Since Nov 19, 2025, the NADAC for AMBRISENTAN 10 MG TABLET has ranged from a low of $8.2094 (Aug 19, 2026) to a high of $9.8462 (Dec 10, 2025), with a median of $8.5213 per EA.
Are there cheaper alternatives to AMBRISENTAN 10 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMBRISENTAN 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures AMBRISENTAN 10 MG TABLET?
AMBRISENTAN 10 MG TABLET (NDC 60505455303) is labeled by Apotex Corp., and CMS classifies it as a generic product.